Precision medicine - At the heart of heart failure therapy


To select the right patient for the right treatment at the right time 


A MedTech start-up founded in 2019 based on patented technology. We provide a cutting-edge solution for guiding pacemaker implantation and optimize cardiac resynchronization therapy (CRT). Using a novel, on-sight evaluation approach, the underlying substrate of the dyssynchronous heart failure is identified and optimal therapy can be applied.


Our team has a long history of research, innovation, and product development within the field of cardiology, which has allowed the design of a disruptive product that meets the company's goals. The team is our biggest asset - with three Ph.D. and four master's degrees, a combined experience of 35 years, and an average age of 34 years.

Find out more...

Investment opportunity

The company offers a unique opportunity to take part in the MedTech endeavor together with a dedicated team of excellent medical and computer engineering experts.

We are searching for people who share our vision of expanding treatment opportunities while becoming world leaders within the field. Get in touch...

Supported by: